Price $158.97 |
Market Cap
31.33B
|
Sector Health Care |
Div. Growth
4.80%
|
|
P/E
19.0
|
P/B
-
|
P/S
0.13
|
Dividend %
1.20%
|
|
P/CF
-
|
P/FCF
19.6
|
Op. Cash Flow
2.55M
|
FCF
7.9
|
|
Op. Margin
1.00%
|
Net Margin
0.70%
|
ROE
-
|
ROI
34.50%
|
|
ROA
3.00%
|
EPS Growth
6.90%
|
Current Ratio
0.9
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cidara Therapeutics Inc (CDTX) | $1.26 | - | - | 129.6M | Strong Buy |
| Dynatronics Corp (DYNT) | $1.56 | - | - | 7.4M | Strong Buy |
| Avalo Therapeutics Inc (AVTX) | $1.61 | - | - | 32.3M | Strong Buy |
| Psychemedics Corp. (PMD) | $5.45 | - | 4.70% | 33.1M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $3.92 | - | - | 110.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
